We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+8.84%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$212B
AUM Growth
+$25.4B
Cap. Flow
+$11.1B
Cap. Flow %
5.24%
Top 10 Hldgs %
35.63%
Holding
5,234
New
558
Increased
1,559
Reduced
2,300
Closed
327

Sector Composition

Rank Sector Weight
1 Technology 13.39%
2 Financials 7.95%
3 Communication Services 5.87%
4 Consumer Discretionary 5.85%
5 Healthcare 5.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GNMK
5151
DELISTED
GenMark Diagnostics, Inc
GNMK
-696,710
Closed -$16.7M
EGOV
5152
DELISTED
NIC Inc
EGOV
-145,710
Closed -$4.94M
IPHI
5153
DELISTED
INPHI CORPORATION
IPHI
-1,357,169
Closed -$242M
FPRX
5154
DELISTED
Five Prime Therapeutics, Inc.
FPRX
-136,346
Closed -$5.14M
VAR
5155
DELISTED
Varian Medical Systems, Inc.
VAR
-2,639,703
Closed -$466M
MIK
5156
DELISTED
Michaels Stores, Inc
MIK
-422,404
Closed -$9.27M
PS
5157
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
-547,006
Closed -$12.2M
SMTX
5158
DELISTED
SMTC Corporation
SMTX
-1,508
Closed -$9K
HMSY
5159
DELISTED
HMS Holdings Corp.
HMSY
-1,023,383
Closed -$37.8M
SYNC
5160
DELISTED
Synacor, Inc.
SYNC
-140
Closed
GEN
5161
DELISTED
Genesis Healthcare, Inc.
GEN
-566
Closed
ZAGG
5162
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
-124,568
Closed -$534K
CEL
5163
DELISTED
Cellcom Israel, Ltd.
CEL
-10,420
Closed -$39K
GNCA
5164
DELISTED
Genocea Biosciences, Inc.
GNCA
-1,763
Closed -$5K
ONCS
5165
DELISTED
OncoSec Medical Incorporated
ONCS
-40
Closed -$4K
MFGP
5166
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
$0 ﹤0.01%
54
-10
-16% -$72
MACK
5167
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
-320
Closed -$2K
CBPO
5168
DELISTED
China Biologic Products Holdings, Inc.
CBPO
-9,892
Closed -$1.17M
ATVI
5169
PUT
DELISTED
Activision Blizzard
ATVI
-80,000
Closed -$7.44M
BSCM
5170
DELISTED
Invesco BulletShares 2022 Corporate Bond ETF
BSCM
$0 ﹤0.01%
+22
New +$476
FM
5171
DELISTED
iShares Frontier and Select EM ETF
FM
-361
Closed -$11K
MTL
5172
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
$0 ﹤0.01%
39
+5
+15% +$10
DFVL
5173
DELISTED
iPath US Treasury 5-year Bull ETN
DFVL
-67,400
Closed -$5.42M
GFN
5174
DELISTED
General Finance Corporation
GFN
-8,642
Closed -$105K
CKH
5175
DELISTED
Seacor Holdings Inc.
CKH
-70,655
Closed -$2.88M

Similar funds

Barclays's Q2 2021 Portfolio in Review

As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.

  • Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
  • Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
  • Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
  • Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
  • Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
  • Barclays opened 558 new positions and closed 327 in Q2 2021.
  • Barclays's portfolio value rose 14% quarter-over-quarter to $212B.

Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.